Drug Approvals
This Biotech Stock Pick Is Just Starting to Make Beautiful Music
Things have started to turn up for this midcap name. Look for these shares to end the year on an up note.
AbbVie's Quant Upgrade Gets My Attention. Bullish Charts Keep It
With two approaches on the same page, here's how we'd trade this drugmaker's stock.
Who Would Bet Against Eli Lilly? I Would and Here's How
Let me show you an options play and tell why now could be the time to use it.
As Novo Nordisk Surges on Ozempic, Wegovy, Is the Stock Looking a Little Heavy?
Unbelievably, there may be more interest in weight loss than AI right now.
I Like This Small-Cap Stock Long-Term: This Is How I'll Trade It
It's small-cap earnings season and the market is under pressure. This may create some good opportunities.
Eli Lilly Soars as Mounjaro, Growth Products Take Off: We're Upping Our Target
Here's how traders can play the stock.
Sage Therapeutics Shares Plunge After FDA Rejection
Is this a buy the dip move?
2 Biotech Stocks to Watch as Their Growth Stories Brighten
These small and mid-cap names have seen major news of late.
Abbott Laboratories Has Rallied Towards a Major Breakout Area
As we check the charts, I have two new price targets.
Let's Check the Safety and Efficacy of Amgen's Charts Ahead of Earnings
AMGN's quarterly report is due in early August, so will buying the stock now pose any side effects?